Study offers way to increase immune checkpoint inhibitor effectiveness in patients with MTAP-deleted cancers

Loss of the «housekeeping» gene methylthioadenosine phosphorylase, or MTAP, is a common event in cancer. Patients with melanoma or bladder cancer whose tumor cells lack a functioning version of the gene tend not to respond to immune checkpoint inhibitors, although the reasons haven’t been clear.